cGAS-STING Pathway's Impact on Intestinal Barrier

Area of Science:

• Immunology
• Gastroenterology
• Molecular Biology

Background:

• Intestinal inflammation and barrier dysfunction are linked to metabolic issues.
• The cyclic GMP-AMP synthase-stimulator of interferon genes (cGAS-STING) pathway is a key signaling pathway involved in innate immunity.
• This pathway responds to cytosolic double-stranded DNA (dsDNA).

Purpose of the Study:

• To review the role and impact of the cGAS-STING pathway on intestinal barrier function.
• To explore the molecular mechanisms of cGAS-STING signaling in the gut.
• To understand how cGAS-STING activation affects intestinal epithelial cells and immune responses.

Main Methods:

• Literature review of studies on the cGAS-STING pathway in intestinal inflammation.
• Analysis of molecular mechanisms involving cGAS, STING, TBK1, IRF3, and NF-κB.
• Examination of the pathway's effects on intestinal epithelial cells (IECs) and immune cells.

Main Results:

• cGAS activation by dsDNA produces cyclic GMP-AMP (cGAMP).
• cGAMP binding to STING initiates signaling cascades involving TBK1, IRF3, and NF-κB.
• This activation leads to the production of type I interferon and proinflammatory cytokines.
• The pathway's effects differ across various intestinal cell types.

Conclusions:

• The cGAS-STING pathway significantly influences intestinal barrier integrity and inflammation.
• Dysregulation of this pathway may contribute to metabolic disturbances associated with compromised gut barrier function.
• Further research into the cGAS-STING pathway could reveal therapeutic targets for intestinal diseases.